Literature DB >> 8509165

Distribution of metallothionein in the human central nervous system.

H G Blaauwgeers1, P A Sillevis Smitt, J M De Jong, D Troost.   

Abstract

The distribution of metallothionein (MT), a metal-binding protein, was examined immunohistochemically in the normal human brain and spinal cord. Paraffin-embedded brain tissue from three patients who had died from a non-neurological disease and were free of histopathological central nervous system alterations were processed. The results of the present study demonstrate that MT is readily detectable in a subgroup of astrocytes in the normal human brain. MT staining is most intense on grey matter astrocytes that bear short stout processes and which probably represent protoplasmic astrocytes. Using anti-MT and anti-glial fibrillary acidic protein immunostaining, we could demonstrate two subpopulations of astrocytes that were mutually exclusive. The functional significance of MT-expression in protoplasmic astrocytes is not entirely clear. Metal detoxification is only one of the many postulated functions of MT. The finding that staining for MT permits subtyping of astrocytes may be of great importance in glia research and surgical pathology of the human brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509165     DOI: 10.1002/glia.440080108

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  10 in total

1.  Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis.

Authors:  S Kato; H Hayashi; K Nakashima; E Nanba; M Kato; A Hirano; I Nakano; K Asayama; E Ohama
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

Review 3.  Metallothionein biology in the ageing and neurodegenerative brain.

Authors:  J Dittmann; S J Fung; J C Vickers; M I Chuah; R S Chung; A K West
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures.

Authors:  J C Erickson; G Hollopeter; S A Thomas; G J Froelick; R D Palmiter
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

5.  Metallothioneins and brain injury: What transgenic mice tell us.

Authors:  Juan Hidalgo
Journal:  Environ Health Prev Med       Date:  2004-05       Impact factor: 3.674

6.  Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.

Authors:  Jorge I Alvarez; Janani Krishnamurthy; Judy M Teale
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

7.  The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury.

Authors:  K Leyshon-Sørland; B Jasani; A J Morgan
Journal:  Histochem J       Date:  1994-02

8.  Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus.

Authors:  Arnulf H Koeppen; R Liane Ramirez; Devin Yu; Sarah E Collins; Jiang Qian; Patrick J Parsons; Karl X Yang; Zewu Chen; Joseph E Mazurkiewicz; Paul J Feustel
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

Review 9.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

10.  Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.

Authors:  Ryo Kikuoka; Ikuko Miyazaki; Natsuki Kubota; Megumi Maeda; Daiki Kagawa; Masaaki Moriyama; Asuka Sato; Shinki Murakami; Yoshihisa Kitamura; Toshiaki Sendo; Masato Asanuma
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.